MENU

EQ Stock Equillium (EQ, $0.93) Stochastic Oscillator left the oversold zone on August 12, 2025

A.I.dvisor
at Tickeron.com
Loading...
EQ - Equillium
Stochastic signal
Bullish Trend
Odds of UP Trend
Tickeron
Stochastic signal
Price: $0.9341
Daily change: +$0.0483 (+5.45%)
Daily volume: 13.3M
Industry: Biotechnology
This is a signal that EQ's price trend could be reversing, and it may be an opportunity to buy the stock or explore call options. A.I.dvisor identified 63 similar cases where EQ's stochastic oscillator exited the oversold zone, and of them led to successful outcomes. Odds of Success:

EQ in upward trend: 10-day moving average moved above 50-day moving average on July 18, 2025

The 10-day moving average for EQ crossed bullishly above the 50-day moving average on July 18, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 63 cases where EQ's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on August 01, 2025. You may want to consider a long position or call options on EQ as a result. In of 77 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

EQ moved above its 50-day moving average on July 14, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where EQ advanced for three days, in of 255 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 118 cases where EQ Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EQ declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

EQ broke above its upper Bollinger Band on August 11, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. EQ’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.052) is normal, around the industry mean (19.528). P/E Ratio (0.000) is within average values for comparable stocks, (52.377). EQ's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.945). Dividend Yield (0.000) settles around the average of (0.042) among similar stocks. P/S Ratio (2.448) is also within normal values, averaging (294.394).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EQ’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
EQ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. EQ showed earnings on May 08, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer of products for severe immune-inflammatory disorders

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
2223 Avenida De La Playa
Phone
+1 858 240-1200
Employees
44
Web
https://www.equilliumbio.com